DK0556051T3 - Anvendelse af bilobalid samt derivater deraf til behandling af en infektion hos et individ og farmaceutiske præparater tilpasset denne anvendelse. - Google Patents

Anvendelse af bilobalid samt derivater deraf til behandling af en infektion hos et individ og farmaceutiske præparater tilpasset denne anvendelse.

Info

Publication number
DK0556051T3
DK0556051T3 DK93301010.0T DK93301010T DK0556051T3 DK 0556051 T3 DK0556051 T3 DK 0556051T3 DK 93301010 T DK93301010 T DK 93301010T DK 0556051 T3 DK0556051 T3 DK 0556051T3
Authority
DK
Denmark
Prior art keywords
bilobalide
derivatives
treatment
application
pharmaceutical compositions
Prior art date
Application number
DK93301010.0T
Other languages
Danish (da)
English (en)
Inventor
Ezio Bombardelli
Mario Ghione
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK0556051T3 publication Critical patent/DK0556051T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK93301010.0T 1992-02-13 1993-02-12 Anvendelse af bilobalid samt derivater deraf til behandling af en infektion hos et individ og farmaceutiske præparater tilpasset denne anvendelse. DK0556051T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202993A GB9202993D0 (en) 1992-02-13 1992-02-13 Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use

Publications (1)

Publication Number Publication Date
DK0556051T3 true DK0556051T3 (da) 1997-07-28

Family

ID=10710286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93301010.0T DK0556051T3 (da) 1992-02-13 1993-02-12 Anvendelse af bilobalid samt derivater deraf til behandling af en infektion hos et individ og farmaceutiske præparater tilpasset denne anvendelse.

Country Status (13)

Country Link
US (1) US5264216A (es)
EP (1) EP0556051B1 (es)
JP (1) JP3156212B2 (es)
KR (1) KR100251394B1 (es)
AT (1) ATE152911T1 (es)
CA (1) CA2089309C (es)
DE (1) DE69310565T2 (es)
DK (1) DK0556051T3 (es)
ES (1) ES2103422T3 (es)
GB (1) GB9202993D0 (es)
GR (1) GR3023414T3 (es)
HK (1) HK1000276A1 (es)
SG (1) SG48723A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US6036696A (en) 1997-12-19 2000-03-14 Stryker Technologies Corporation Guide-pin placement device and method of use
US20080281330A1 (en) * 2005-03-17 2008-11-13 Ferrante Joseph M Medical Securing Member Placement System

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono

Also Published As

Publication number Publication date
CA2089309A1 (en) 1993-08-14
US5264216A (en) 1993-11-23
ES2103422T3 (es) 1997-09-16
EP0556051B1 (en) 1997-05-14
DE69310565D1 (de) 1997-06-19
JPH0624974A (ja) 1994-02-01
SG48723A1 (en) 1998-05-18
CA2089309C (en) 2004-11-30
GB9202993D0 (en) 1992-03-25
JP3156212B2 (ja) 2001-04-16
DE69310565T2 (de) 1997-12-18
EP0556051A1 (en) 1993-08-18
GR3023414T3 (en) 1997-08-29
KR930017577A (ko) 1993-09-20
ATE152911T1 (de) 1997-05-15
HK1000276A1 (en) 1998-02-20
KR100251394B1 (ko) 2000-05-01

Similar Documents

Publication Publication Date Title
ATE144704T1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
FI884013A0 (fi) Konjugat av cytokiner med immunoglobuliner.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
ATE117548T1 (de) Pharmazeutische zubereitungen zur verhütung von arzneimitteltoleranz.
KR910019618A (ko) 발기부전증 치료용 제약 조성물
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
ATE173627T1 (de) Medizinische zusammensetzung
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
DK0556051T3 (da) Anvendelse af bilobalid samt derivater deraf til behandling af en infektion hos et individ og farmaceutiske præparater tilpasset denne anvendelse.
KR960705578A (ko) 경증 질환을 가진 b형 간염 보균자의 치료방법(method for treating hepatitis b carriers with minimal disease)
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
DE3689254D1 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
DE3869156D1 (de) Fungizide 2-anilinthiazoline.
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
ATE227573T1 (de) Orale oder intramuskuläre behandlung von pankreaskrebs durch wasserunlösliches s- camptothecin mit geschlossenem lactonring
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
ITFI920128A1 (it) Analoghi esapeptidici lineari o ciclici delle tachichinine e loro sali farmaceuticamente accettabili, loro preparazione e composizioni farmaceutiche che li contengono
TH13285EX (th) สารประกอบที่ใช้บำบัดโรคที่เกี่ยวกับการเสื่อมของประสาท
NO920719L (no) Injiserbare s-adenosyl-l-metionin-holdige preparater